SLC26A2

Chr 5AR

solute carrier family 26 member 2

Also known as: D5S1708, DTD, DTDST, EDM4, MST153, MSTP157

The diastrophic dysplasia sulfate transporter is a transmembrane glycoprotein implicated in the pathogenesis of several human chondrodysplasias. It apparently is critical in cartilage for sulfation of proteoglycans and matrix organization. [provided by RefSeq, Jul 2008]

Primary Disease Associations & Inheritance

Achondrogenesis IBMIM #600972
AR
Atelosteogenesis, type IIMIM #256050
AR
De la Chapelle dysplasiaMIM #256050
AR
Diastrophic dysplasiaMIM #222600
AR
Diastrophic dysplasia, broad bone-platyspondylic variantMIM #222600
AR
Epiphyseal dysplasia, multiple, 4MIM #226900
AR
UniProtAchondrogenesis 1B
UniProtAtelosteogenesis 2
UniProtMultiple epiphyseal dysplasia 4
0
Active trials
202
Pathogenic / LP
841
ClinVar variants
14
Pubs (1 yr)
0.0
Missense Z
1.11
LOEUF
Clinical SummarySLC26A2
🧬
Gene-Disease Validity (ClinGen)
SLC26A2-related skeletal dysplasia · ARDefinitive

Definitive — sufficient evidence for diagnostic panels

Population Constraint (gnomAD)
Low constraint (pLI 0.00) — loss-of-function variants are relatively tolerated in the population.
📋
ClinVar Variants
202 Pathogenic / Likely Pathogenic· 313 VUS of 841 total submissions
📖
GeneReview available — SLC26A2
Authoritative clinical overview · Recommended first read
Open GeneReview ↗

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint
1.11LOEUF
pLI 0.000
Z-score 1.23
OE 0.68 (0.441.11)
Tolerant

Highly tolerant — LoF variants common in population

Missense Constraint
0.03Z-score
OE missense 1.00 (0.911.08)
370 obs / 371.7 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios
LoF OE0.68 (0.441.11)
00.351.4
Missense OE1.00 (0.911.08)
00.61.4
Synonymous OE0.95
01.21.6
LoF obs/exp: 12 / 17.6Missense obs/exp: 370 / 371.7Syn Z: 0.42
DNGOF
DN
0.78top 25%
GOF
0.76top 25%
LOF
0.2581th %ile

This gene has evidence for multiple mechanisms of pathogenicity (dominant-negative and gain-of-function). Both the Badonyi & Marsh prediction and the broader genomic evidence point to dominant-negative as the predominant mechanism. Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

DNprediction above median
GOFprediction above median

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

841 submitted variants in ClinVar

Classification Summary

Pathogenic76
Likely Pathogenic126
VUS313
Likely Benign260
Benign17
Conflicting49
76
Pathogenic
126
Likely Pathogenic
313
VUS
260
Likely Benign
17
Benign
49
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
42
4
30
0
76
Likely Pathogenic
72
24
30
0
126
VUS
3
212
90
8
313
Likely Benign
0
5
22
233
260
Benign
0
1
16
0
17
Conflicting
49
Total117246188241841

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

SLC26A2 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Gene2Phenotype Curations

SLC26A2-related multiple epiphyseal dysplasia

definitive
ARUndeterminedAltered Gene Product Structure
Dev. DisordersSkeletal
G2P ↗
missense variantinframe deletioninframe insertion

SLC26A2-related achondrogenesis

definitive
ARLoss Of FunctionAbsent Gene Product
Dev. DisordersSkeletal
G2P ↗

Gene2Phenotype curations · DECIPHER consortium patient cohort (public variants) · deciphergenomics.org

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →
Clinical Literature
Landmark / reviewRecent case evidence